Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma-Reference-Cited by-同舟云学术

Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma

Published:2014-12-18 Issue:5 Volume:6 Page:3178-3194
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Jiang Xingming¹,Ma Ning²,Wang Dayong²,Li Fuyuan³,He Rongzhang²,Li Dongliang²,Zhao Ruiqi²,Zhou Qingxin¹,Wang Yimin¹,Zhang Fumin¹,Wan Ming¹,Kang Pengcheng¹,Gao Xu²,Cui Yunfu¹

Affiliation:

1. Department of Hepatopancreatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China

2. Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China

3. Center for Endemic Disease Control, Harbin Medical University, Harbin, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin Regulates the miR-205/VEGFA Axis in Renal Cell Carcinoma Cells: Exploring a Clinical Synergism with Tyrosine Kinase Inhibitors;Urologia Internationalis;2023-11-30

2. Spotlight on the Expanding Role of DANCR in Tumorigenesis and Tumor Progression;Iranian Red Crescent Medical Journal;2023-05-18

3. Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review;Biomolecules;2023-01-29

4. LINC02381 suppresses cell proliferation and promotes apoptosis via attenuating IGF1R/PI3K/AKT signaling pathway in breast cancer;Functional & Integrative Genomics;2023-01-17

5. Spotlight on the expanding role of miR-647 in human cancers;Advanced Biomedical Research;2023